Steve Evans

CEO and Acting Chair at Oncolyze

Steve Evans is currently the CEO and Acting Chair at Oncolyze, an early-stage oncology biotech company. Steve also has experience as the CEO at Althera. At Oncolyze, Steve is leading the development of their lead drug candidate, OM-301, which has a unique mechanism of action targeting cancer cells.

Links

Org chart

View in org chart

Peers

Reports

Alex Stojanovic

Fractional COO

Barbara A. Carlin

Chief Financial Officer

Larry Altstiel

Chief Scientific Officer

View in org chart

Timeline

CEO and Acting Chair
August, 2011 - present

A panel showing how The Org can help with contacting the right person.